CLOROCALCIN 12.2% oral drops solution medication leaflet

A12AA07 calcium chloride • Alimentary tract and metabolism | Calcium

Calcii chloridum is a medication used for the treatment of acute hypocalcemia, hyperkalemia, hypermagnesemia, and calcium channel blocker overdose. It provides calcium, an essential mineral for the normal functioning of the nervous, muscular, and cardiovascular systems, as well as for blood coagulation and bone health.

The medication is administered intravenously, usually as a slow injection or infusion, as directed by a doctor. The dosage is adjusted based on the severity of the condition and the patient's response to treatment.

Common side effects include a sensation of warmth, metallic taste, nausea, and irritation at the injection site. In rare cases, more severe adverse effects such as cardiac arrhythmias, hypercalcemia, or tissue necrosis in cases of extravascular administration may occur.

Calcii chloridum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, administration should be performed by qualified medical personnel to minimize the risks associated with this medication.

General data about CLOROCALCIN 12.2%

Substance: calcium chloride

Date of last drug list: 01-07-2013

Commercial code: W00722001

Concentration: 12.2%

Pharmaceutical form: oral drops solution

Quantity: 1

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: BIOFARM S.A. - ROMANIA

Holder: BIOFARM S.A. - ROMANIA

Number: 11967/2019/01

Shelf life: 2 years-after packaging for sale;after the first opening of the bottle-30 days

Pharmaceutical forms available for calcium chloride

Concentrations available for calcium chloride

100mmol/l, 12.2%, 340mmol/l

Other substances similar to calcium chloride